Adapted from Biofabrication The high-throughput 3D bioprinting setup developed by researchers at UC San Diego shown performing prints on a standard 96-well plate. The platform can be used to speed up the process of testing and approving new medications for clinical and commercial use. Researchers have developed a rapid-production 3D bioprinter that could also speed up the development of new medications by providing living human tissue samples in record time, they said. A team of nanoengineers at the University of California San Diego (UCSD) led by Shaochen Chen, a professor of nanoengineering at the UC San Diego Jacobs School of Engineering, developed the printer, which can produce a 96-well array of samples within 30 minutes, he said. At this speed, pharmaceutical companies can save a significant amount of time during the preclinical drug screening and disease modeling phases of developing new drugs, researchers said.